These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21962240)

  • 21. [Antineuronal autoantibodies in paraneoplastic neurological diseases].
    Blaes F; Tschernatsch M
    Dtsch Med Wochenschr; 2008 Feb; 133(6):252-5. PubMed ID: 18236352
    [No Abstract]   [Full Text] [Related]  

  • 22. Motor neuron involvement in anti-Ma2-associated paraneoplastic neurological syndrome.
    Vogrig A; Joubert B; Maureille A; Thomas L; Bernard E; Streichenberger N; Cotton F; Ducray F; Honnorat J
    J Neurol; 2019 Feb; 266(2):398-410. PubMed ID: 30498914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Paraneoplastic cerebral syndromes with oto-neuro-ophthalomologic manifestations].
    Dalmau J; Porta-Etessam J
    Rev Neurol; 2000 Dec 16-31; 31(12):1213-9. PubMed ID: 11205562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychiatric manifestations of paraneoplastic disorders.
    Kayser MS; Kohler CG; Dalmau J
    Am J Psychiatry; 2010 Sep; 167(9):1039-50. PubMed ID: 20439389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paraneoplastic antibody during follow-up of a patient with anti-Ri-associated paraneoplastic neurological syndrome.
    Stich O; Rasiah C; Rauer S
    Acta Neurol Scand; 2009 May; 119(5):338-40. PubMed ID: 18822086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: a case report and a review of the literature.
    Weizman DA; Leong WL
    J Surg Oncol; 2004 Sep; 87(3):143-5. PubMed ID: 15334643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroimmunology of the paraneoplastic neurological degenerations.
    Roberts WK; Darnell RB
    Curr Opin Immunol; 2004 Oct; 16(5):616-22. PubMed ID: 15342008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Paraneoplastic peripheral neuropathy due to solid cancers].
    Antoine JC; Honnorat J
    Rev Prat; 2008 Nov; 58(17):1890-1. PubMed ID: 19180788
    [No Abstract]   [Full Text] [Related]  

  • 29. Paraneoplastic brainstem encephalitis with tetraparesis in a patient with anti-Ri antibodies.
    Rajabally YA; Naz S; Farrell D; Abbott RJ
    J Neurol; 2004 Dec; 251(12):1528-9. PubMed ID: 15645357
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunology in the clinical practice. XVI. Paraneoplastic syndromes of the nervous system: pathogenesis and diagnosis].
    Smitt PA; de Leeuw B; Vecht CJ
    Ned Tijdschr Geneeskd; 1998 Jul; 142(29):1652-8. PubMed ID: 9763856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-neuronal nuclear antibodies, type 1 and type 2].
    Hirose G
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():522-5. PubMed ID: 20942119
    [No Abstract]   [Full Text] [Related]  

  • 32. [Paraneoplastic neurological syndromes: from the diagnosis of exclusion to the use of immunological and molecular markers].
    Dalmau J
    Neurologia; 2000 Mar; 15(3):114-26. PubMed ID: 10846872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative evidence of anti-Ri specific intrathecal antibody synthesis and quantification of anti-Ri antibodies in serial samples from a patient with anti-Ri syndrome.
    Stich O; Rauer S
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):282-3. PubMed ID: 16421147
    [No Abstract]   [Full Text] [Related]  

  • 34. [Stiff-person syndrome and other myelopathies constitute paraneoplastic neurological syndromes].
    Ishii A
    Brain Nerve; 2010 Apr; 62(4):377-85. PubMed ID: 20420178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic tests: Anti-Purkinje cell antibody (Anti-Yo/type 1 antibody)].
    Tanaka K
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():479-82. PubMed ID: 16111307
    [No Abstract]   [Full Text] [Related]  

  • 36. Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies.
    Vale TC; Pedroso JL; Dutra LA; Azevedo L; Filho LH; Prado LB; Hoftberger R; Prado GF; Barsottini OG
    Lancet; 2017 Apr; 389(10076):1367-1368. PubMed ID: 28379152
    [No Abstract]   [Full Text] [Related]  

  • 37. Paraneoplastic neurologic syndrome associated with small breast cancer: diagnostic value of FDG-PET for detection of underlying malignancy.
    Kashima Y; Shimojima Y; Fukushima K; Kaneko K; Yazaki M; Hashimoto T; Oguchi K; Ikeda S
    Intern Med; 2005 May; 44(5):522-3. PubMed ID: 15942113
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.
    Rosenfeld MR; Eichen JG; Wade DF; Posner JB; Dalmau J
    Ann Neurol; 2001 Sep; 50(3):339-48. PubMed ID: 11558790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paraneoplastic neurological syndromes].
    Storstein A; Vedeler CA
    Tidsskr Nor Laegeforen; 2009 Mar; 129(6):524-8. PubMed ID: 19282889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
    Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
    Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.